Can you provide the last earnings date for ARCTURUS THERAPEUTICS HOLDIN?
ARCTURUS THERAPEUTICS HOLDIN (ARCT) last reported earnings on 3/3/2026.
ARCTURUS THERAPEUTICS HOLDIN (ARCT) Earnings History & Surprises
NASDAQ:ARCT • US03969T1097
Current stock price
8.87 USD
+0.57 (+6.87%)
At close:
8.91 USD
+0.04 (+0.45%)
After Hours:
ARCT Earnings overview
Past quarterly earnings results for ARCTURUS THERAPEUTICS HOLDIN (ARCT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.11
- Revenue Estimate
- 7.376M
Last Reported
Most Recent- Release Date
- Mar 3, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$1.03
- EPS Surprise
- -41.61%
- Revenue Surprise
- -60.07%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.03 | -0.73 | -41.61% | 7.21% | 7.196M | 18.022M | -60.07% | -68.39% |
| Q3 2025 | -0.49 | -0.84 | 41.65% | -88.46% | 17.151M | 19.648M | -12.71% | -58.84% |
| Q2 2025 | -0.34 | -0.91 | 62.62% | 46.88% | 28.301M | 21.343M | 32.60% | -43.24% |
| Q1 2025 | -0.52 | -1.36 | 61.70% | 48.00% | 29.382M | 26.792M | 9.67% | -22.70% |
| Q4 2024 | -1.11 | -0.56 | -98.22% | -246.88% | 22.766M | 45.543M | -50.01% | -33.02% |
| Q3 2024 | -0.26 | -1.24 | 79.04% | 57.38% | 41.673M | 37.329M | 11.64% | -7.68% |
| Q2 2024 | -0.64 | -1.63 | 60.74% | 67.68% | 49.859M | 22.13M | 125.30% | 373.99% |
| Q1 2024 | -1.00 | -1.21 | 17.53% | -153.48% | 38.012M | 17.895M | 112.42% | -52.32% |
| Q4 2023 | -0.32 | -1.01 | 68.38% | -107.22% | 33.989M | 38.613M | -11.98% | -78.80% |
| Q3 2023 | -0.61 | -1.73 | 64.65% | 54.14% | 45.14M | 16.182M | 178.95% | 236.87% |
| Q2 2023 | -1.98 | -0.21 | -821.08% | -141.46% | 10.519M | 49.472M | -78.74% | -61.18% |
| Q1 2023 | 1.87 | 0.06 | 2,968.34% | 196.39% | 79.729M | 38.694M | 106.05% | 1,433.25% |
| Q4 2022 | 4.43 | 1.00 | 343.79% | 401.36% | 160.3M | 74.137M | 116.22% | 2,663.79% |
| Q3 2022 | -1.33 | -1.85 | 28.13% | 35.12% | 13.4M | 3.492M | 283.73% | 458.33% |
| Q2 2022 | -0.82 | -1.94 | 57.69% | 60.39% | 27.1M | 2.131M | 1,171.70% | 1,255.00% |
| Q1 2022 | -1.94 | -1.47 | -32.29% | 9.77% | 5.2M | 6.423M | -19.04% | 147.62% |
| Q4 2021 | -1.47 | -1.76 | 16.39% | -17.60% | 5.8M | 15.01M | -61.36% | 163.64% |
| Q3 2021 | -2.05 | -1.62 | -26.20% | -122.83% | 2.4M | 22.191M | -89.18% | 4.35% |
| Q2 2021 | -2.07 | -2.19 | 5.51% | -276.36% | 2M | 2.362M | -15.33% | -13.04% |
| Q1 2021 | -2.15 | -1.28 | -68.19% | -220.90% | 2.1M | 2.59M | -18.92% | -19.23% |
| Q4 2020 | -1.25 | -0.90 | -39.25% | - | 2.2M | 2.405M | -8.52% | - |
| Q3 2020 | -0.92 | -0.50 | -85.11% | - | 2.3M | 3.064M | -24.93% | - |
| Q2 2020 | -0.55 | -0.56 | 2.35% | - | 2.3M | 3.61M | -36.29% | - |
| Q1 2020 | -0.67 | -0.62 | -8.19% | - | 2.6M | 5.069M | -48.71% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
31.09%
Max EPS beat (4)
62.62%
Min EPS beat (4)
-41.61%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-7.63%
Max Revenue beat (4)
32.60%
Min Revenue beat (4)
-60.07%
Analysis
In the last 4 quarters, ARCT has beaten EPS estimates in 3 out of 4 releases
ARCT has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, ARCT has beaten the EPS estimates by 31.1% on average.
In the last 4 quarters, ARCT reported -7.6% below the revenue estimates on average.
Related analysis
ARCTURUS THERAPEUTICS HOLDIN / ARCT Earnings FAQ
Did ARCT stock beat earnings estimates in the most recent quarter?
ARCTURUS THERAPEUTICS HOLDIN (ARCT) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does ARCTURUS THERAPEUTICS HOLDIN (ARCT) beat earnings estimates?
In the last 4 quarters, ARCTURUS THERAPEUTICS HOLDIN (ARCT) has beaten EPS estimates in 3 out of 4 releases.